Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Ovarian Tissue Cryopreservation for Fertility Preservation

for
Cancer, Autoimmune Diseases
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Female

Age: 0 - 39

Code: NCT05875155

Recruiting

IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study

for
Neurologic Disorder
Location: Overland Park KS
Sponsor: Rehabilitation Hospital of Overland Park

Sex: All

Age: 18+

Code: NCT05652946

Recruiting

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

for
Autoimmune Disorders, Systemic Sclerosis,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06434363

Phase 1, Phase 2, Recruiting

Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)

for
Spinal Cord Injuries, Spinal Cord Diseases,
Location: West Orange NJ
Sponsor: Kessler Foundation

Sex: All

Age: 18 - 70+

Code: NCT05731986

Recruiting

Neurosciences Research Repository

for
Neurological Conditions
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0+

Code: NCT00857922

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning

for
Spinal Cord Injuries, Neurological Injury, Paralysis,
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT05094362

Recruiting

AnovaOS Network Powered Patient Registry

for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc

Sex: All

Age: 18+

Code: NCT05013944

Recruiting

ILD-SARDs Registry and Biorepository

for
Interstitial Lung Disease, Systemic Autoimmune Disease,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT05007340

Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

for
Patients Undergoing Routine Health Care, Heart Diseases,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT01280825

Recruiting

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

for
Primary Immune Regulatory Disorder,
Location: New York NY, Philadelphia PA, Atlanta GA, Milwaukee WI,
Sponsor: Joseph Oved

Sex: All

Age: 0+

Code: NCT05787574

Phase 2, Recruiting

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

for
Ulcerative Colitis, Inflammatory Bowel Diseases,
Location: Miami FL, Tampa FL, Cleveland OH, Roswell GA
Sponsor: Athos Therapeutics Inc

Sex: All

Age: 18 - 70+

Code: NCT07513181

Phase 2, Recruiting

Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

for
Hypogammaglobulinemia, Autoimmune Conditions,
Location: Irving TX, Mesa AZ, Scottsdale AZ
Sponsor: Octapharma

Sex: All

Age: 18+

Code: NCT07220915

Phase 3, Recruiting

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

for
Refractory Autoimmune Diseases
Location: Boston MA, Durham NC
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07115745

Phase 1, Recruiting

Stakeholders of Rare Diseases Informing Values In Neuroethics

for
Rare Disorder, Disorder, Neurologic
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT07314736

Recruiting

The "What Is Important to Us" Communication Intervention Pilot Clinical Trial

for
Critical Illness, Neurologic Disorder
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0+

Code: NCT06208332

Phase 2, Recruiting

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

for
Central Auditory Processing Disorder,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 45 - 65

Code: NCT07304024

Phase 1, Phase 2, Recruiting

The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions

for
Rheumatic Diseases, Inflammatory Arthritis,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 60+

Code: NCT07278609

Recruiting

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 2 - 70+

Code: NCT07202598

Phase 2, Recruiting

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells

for
Glucose, Metabolism, Isotope Labeling,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT06930976

Recruiting

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

for
Spinal Fusion, Hyperglycemia, Postoperative Pain Management,
Location: St Louis MO
Sponsor: Alexander T. Yahanda

Sex: All

Age: 18+

Code: NCT07218133

Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis